R Pugh

1.4k total citations
13 papers, 1.1k citations indexed

About

R Pugh is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R Pugh has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R Pugh's work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). R Pugh is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). R Pugh collaborates with scholars based in United States, Switzerland and India. R Pugh's co-authors include Richard Elledge, Gary M. Clark, C. Kent Osborne, Peter M. Ravdin, Silvana Martino, Daniel R. Ciocca, Joe M. O’Sullivan, D. Craig Allred, D. Craig Allred and Stephanie Green and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

R Pugh

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Pugh United States 9 739 490 299 254 155 13 1.1k
Ulla Johansson Sweden 16 598 0.8× 493 1.0× 272 0.9× 261 1.0× 168 1.1× 21 1.1k
Antonio Durando Italy 16 516 0.7× 509 1.0× 318 1.1× 146 0.6× 137 0.9× 42 976
S. Ashley United Kingdom 9 772 1.0× 432 0.9× 234 0.8× 331 1.3× 185 1.2× 12 1.1k
A McKinna United Kingdom 11 407 0.6× 232 0.5× 255 0.9× 210 0.8× 125 0.8× 14 756
G. Reiner Austria 21 742 1.0× 604 1.2× 272 0.9× 329 1.3× 240 1.5× 46 1.2k
Encarna Adrover Spain 14 864 1.2× 366 0.7× 297 1.0× 113 0.4× 89 0.6× 40 1.1k
M Brunet France 16 763 1.0× 709 1.4× 471 1.6× 326 1.3× 254 1.6× 26 1.5k
B. Lisboa Germany 12 474 0.6× 376 0.8× 203 0.7× 207 0.8× 54 0.3× 23 788
JFR Robertson United Kingdom 12 435 0.6× 333 0.7× 327 1.1× 138 0.5× 184 1.2× 13 830
Peggy Manders Netherlands 21 622 0.8× 529 1.1× 579 1.9× 300 1.2× 170 1.1× 43 1.3k

Countries citing papers authored by R Pugh

Since Specialization
Citations

This map shows the geographic impact of R Pugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Pugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Pugh more than expected).

Fields of papers citing papers by R Pugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Pugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Pugh. The network helps show where R Pugh may publish in the future.

Co-authorship network of co-authors of R Pugh

This figure shows the co-authorship network connecting the top 25 collaborators of R Pugh. A scholar is included among the top collaborators of R Pugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Pugh. R Pugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Elledge, Richard, Daniel R. Ciocca, R Pugh, et al.. (1998). HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.. PubMed. 4(1). 7–12. 203 indexed citations
3.
Ciocca, Daniel R., Richard Elledge, Gary M. Clark, et al.. (1998). Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).. PubMed. 4(5). 1263–6. 38 indexed citations
4.
Elledge, Richard, L. G. Howes, Gary M. Clark, et al.. (1997). bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.. Journal of Clinical Oncology. 15(5). 1916–1922. 125 indexed citations
5.
Fisher, Bernard, Stewart Anderson, D. Lawrence Wickerham, et al.. (1997). Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.. Journal of Clinical Oncology. 15(5). 1858–1869. 240 indexed citations
6.
Hoff, Daniel D. Von, et al.. (1991). A Southwest Oncology Group Study on the Use of a Human Tumor Cloning Assay for Predicting Response In Patients With Ovarian Cancer. Obstetrical & Gynecological Survey. 46(7). 471–472. 3 indexed citations
7.
Hoff, Daniel D. Von, Richard A. Kronmal, Sydney E. Salmon, et al.. (1991). A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer. 67(1). 20–27. 54 indexed citations
8.
Chlebowski, Rowan T., et al.. (1987). Doxorubicin and Methotrexate on a Weekly Schedule in Patients with Sarcomas. Oncology. 44(4). 210–213. 3 indexed citations
9.
Chlebowski, Rowan T., R Pugh, John M. Weiner, Jerome B. Block, & Joseph R. Bateman. (1983). Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer a randomized trial. Cancer. 52(4). 606–609. 7 indexed citations
10.
Al‐Sarraf, Muhyi, et al.. (1982). Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.. PubMed. 66(1). 31–5. 104 indexed citations
11.
Eyre, Harmon J., John D. Bonnet, John H. Saiki, et al.. (1981). Study of tamoxifen in metastatic renal cell carcinoma and the influence of certain prognostic factors: a Southwest Oncology Group Study.. PubMed. 65(5-6). 447–51. 17 indexed citations
12.
Rm, Bukowski, Albert F. LoBuglio, Joseph D. McCracken, & R Pugh. (1980). Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.. PubMed. 64(12). 1387–8. 2 indexed citations
13.
Jacobs, Edwin M., et al.. (1971). Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG). Cancer. 27(6). 1302–1305. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulla Johansson Breakdown of academic impact, for papers by Antonio Durando Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by A McKinna Breakdown of academic impact, for papers by G. Reiner Breakdown of academic impact, for papers by Encarna Adrover Breakdown of academic impact, for papers by M Brunet Breakdown of academic impact, for papers by B. Lisboa Breakdown of academic impact, for papers by JFR Robertson Breakdown of academic impact, for papers by Peggy Manders
Rankless by CCL
2026